Nirsevimab to reduce infant morbidity from respiratory syncytial virus
[See related article at www.cmaj.ca/lookup/doi/10.1503/cmaj.240773][1] KEY POINTS Respiratory syncytial virus (RSV) is a common virus that can cause serious infections in newborns and infants, especially those who are born prematurely or have chronic cardiac or respiratory conditions. Until
Authors
- Bahaa Abu-Raya (ORCID: https://orcid.org/0000-0002-3528-0343)
- Pascal M. Lavoie (ORCID: https://orcid.org/0000-0002-2205-0362)
- Joanne M. Langley (ORCID: https://orcid.org/0000-0003-3270-7345)
Institutions
- Nova Scotia Health Authority (CA)
Publication Details
- Journal
- Canadian Medical Association Journal
- Published
- 2024-09-30
- DOI
- https://doi.org/10.1503/cmaj.240780
- Citations
- 6
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 2.32